Nanexa AB (publ) (STO:NANEXA)
Sweden · Delayed Price · Currency is SEK 10.06
-0.14 (-1.37%)
Oct 15, 2026, 1:39 PM CET
Nanexa AB Market Cap
Nanexa AB has a market cap or net worth of 1.92 billion as of October 14, 2026. It is the 20,990th most valuable company in the world and the 260th biggest in Sweden. Its market cap has increased by 487.94% in one year.
Market Cap
1.92B
Enterprise Value
1.87B
Revenue
33.86M
Global Rank
Country Rank
#260 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 17, 2015, Nanexa AB's market cap has increased from 49.07M to 1.92B, an increase of 3,816.24%. That is a compound annual growth rate of 38.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.92B | 172.17% |
| Dec 30, 2025 | 706.11M | 140.91% |
| Dec 30, 2024 | 293.10M | 292.61% |
| Dec 29, 2023 | 74.66M | -46.84% |
| Dec 30, 2022 | 140.43M | -30.75% |
| Dec 30, 2021 | 202.78M | -19.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.28B |
| Cereno Scientific AB | 1.18B |
| Dicot Pharma AB | 856.07M |
| EQL Pharma AB | 659.99M |
| Cinclus Pharma Holding AB | 590.10M |
| Moberg Pharma AB | 533.14M |
| Enzymatica AB | 412.65M |
| Orexo AB | 225.40M |